Arcus Biosciences Announces New Employment Inducement Grants

HAYWARD, Calif.–(Business enterprise WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-centered biopharmaceutical organization functioning to produce finest-in-class cancer therapies, now announced that the Payment Committee of the Company’s Board of Directors granted 10 new workers alternatives to purchase a whole of 141,800 shares of the Company’s prevalent inventory at an